Correlation Between Arcus Biosciences and NRx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcus Biosciences and NRx Pharmaceuticals, you can compare the effects of market volatilities on Arcus Biosciences and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and NRx Pharmaceuticals.

Diversification Opportunities for Arcus Biosciences and NRx Pharmaceuticals

-0.14

Correlation Coefficient

Arcus Biosciences  NRx Pharmaceuticals

Good diversification

The 3 months correlation between Arcus and NRx is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and NRx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Arcus Biosciences and NRx Pharmaceuticals

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 53.11 times less return on investment than NRx Pharmaceuticals. But when comparing it to its historical volatility, Arcus Biosciences is 18.01 times less risky than NRx Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. NRx Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  5.00  in NRx Pharmaceuticals on September 23, 2024 and sell it today you would earn a total of  1.70  from holding NRx Pharmaceuticals or generate 34.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	88.89%
Values	Daily Returns

Arcus Biosciences  vs.  NRx Pharmaceuticals

Arcus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

NRx Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in NRx Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, NRx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Arcus Biosciences and NRx Pharmaceuticals

The main advantage of trading using opposite Arcus Biosciences and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.

The idea behind Arcus Biosciences and NRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.